Prevalence of factor V Leiden mutation in various populations

被引:0
|
作者
Herrmann, FH
Koesling, M
Schroder, W
Altman, R
Bonilla, RJ
Lopaciuk, S
PerezRequejo, JL
Singh, JR
机构
[1] HOSP NATL NINOS,SAN JOSE,COSTA RICA
[2] INST HEMATOL & BLOOD TRANSFUS,WARSAW,POLAND
[3] BANCO SANGRE DE CARABOBO,VALENCIA,VENEZUELA
[4] UNIV AMRITSAR,CTR GENET DISORDERS,AMRITSAR,PUNJAB,INDIA
关键词
frequency of APC resistance; factor V Leiden in Middle and South America; India;
D O I
10.1002/(SICI)1098-2272(1997)14:4<403::AID-GEPI5>3.0.CO;2-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Resistance to activated protein C (APC) is the most common inherited risk factor for venous thrombosis. Most cases of APC resistance are caused by the point mutation nt 1691 G-A in factor V gene, referred to as factor V Leiden mutation. As initially shown in a Dutch population, this mutation has a carrier rate of 2.9%, the most frequent genetic disposition for thrombophilia and deep venous thrombosis. By large-scale epidemiological studies we have determined the prevalence of factor V Leiden mutation in populations from Poland (200), Argentina (215), Venezuela (126), Costa Pica (196), and India (150). The prevalences have been estimated for Poland (Warsaw) 5.0%, Argentina (Buenos Aires) 5.1%, Venezuela (Valencia) 1.6%, Costa Pica (San Jose) 2.0%, and India (Punjab) 1.3%. Based on worldwide distribution, it can be hypothesized that the factor V Leiden mutation has originated and accumulated in central European Caucasians and spread over the world by migration. (C) 1997 Wiiey-Liss, Inc.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 50 条
  • [31] Factor V Leiden mutation and Japanese NIDDM
    M. Odawara
    K. Yamashita
    Diabetologia, 1997, 40 : 1363 - 1364
  • [32] Absence of the factor V Leiden mutation in Ethiopians
    Abdulkadir, J
    Feleke, Y
    Berg, JP
    Falch, JA
    Odegaard, OR
    THROMBOSIS RESEARCH, 1997, 86 (05) : 431 - 432
  • [33] How old is factor V Leiden mutation?
    Pawar, AR
    Shetty, S
    Ghosh, K
    Mohanty, D
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1591 - 1592
  • [34] Factor V Leiden and prothrombin gene mutation
    Björkman, A
    Svensson, PJ
    Hillarp, A
    Burtscher, IM
    Rünow, A
    Benoni, G
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (425) : 168 - 172
  • [35] Factor V Leiden gene mutation and preeclampsia?
    Thorp, JA
    Zucker, ML
    Plapp, FV
    Rachel, JM
    Hinkle, C
    JOURNAL OF MATERNAL-FETAL INVESTIGATION, 1997, 7 (01): : 19 - 20
  • [36] Factor V Leiden mutation and pregnancy complications
    Kjellberg, U.
    van Rooijen, M.
    Bremme, K.
    Hellgren, M.
    THROMBOSIS RESEARCH, 2009, 123 : S152 - S152
  • [37] The impact of the Factor V Leiden mutation on pregnancy
    Spina, V
    Aleandri, V
    Morini, F
    HUMAN REPRODUCTION UPDATE, 2000, 6 (03) : 301 - 306
  • [38] Factor V Leiden mutation in Sneddon syndrome
    Besnier, R
    Francès, C
    Ankri, A
    Aiach, M
    Piette, J
    LUPUS, 2003, 12 (05) : 406 - 408
  • [39] Factor V Leiden mutation and Japanese NIDDM
    Odawara, M
    Yamashita, K
    DIABETOLOGIA, 1997, 40 (11) : 1363 - 1364
  • [40] Automation of the factor V Leiden mutation assay
    Reinartz, J
    McGlennen, R
    Olson, D
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (05): : H1 - H1